STENTYS S.A. announced unaudited revenue results for the second quarter and first half of 2017. For the quarter, the company reported revenues of EUR 1,710,000 against EUR 2,131,800 a year ago. For the half year, the company reported revenues of EUR 3,549,000 against EUR 3,644,400 a year ago. This decline is linked to a negative base effect on the second quarter activity associated with a EUR 426,000 call for tender of MiStent stents won in the Middle East in June 2016. Excluding the impact of this sale, the second quarter revenues were up 0.2%.